Our products in Europe

We provide generic injectable medicines in Europe and other markets around the world.

Related news

Hikma launches generic version of Vyvanse® following FDA approval
31 August 2023
Hikma launches Vancomycin Hydrochloride for Injection, USP, in the US
29 August 2023
Hikma launches Midazolam in 0.9% Sodium Chloride Injection in the US
30 June 2023

Last reviewed on 30 May 2022